Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&lookfor=%22Humans%22&type=Subject&page=9
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&lookfor=%22Humans%22&type=Subject&page=9
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&lookfor=%22Humans%22&type=Subject&page=9
PubPharm (7.554)
81
First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV, in Healthy Adults : VRC 325 (000410): A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability and Immunogenicity of Mosaic Quadrivalent Influenza Vaccine With and Without Adjuplex Compared With a Licensed Inactivated Seasonal QIV, In Healthy Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
82
Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine : A Single-center, Observer-blind Study to Evaluate Safety, Immunogenicity, and Immunological Mechanisms of TETRALITE Influenza Vaccine With LiteVax Adjuvant, in Healthy Participants Aged 60 Years and Older and 18 to 50 Years.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
83
Efficacy Study With QIVc in Pediatric Subjects : A Phase 3, Randomized, Observer-blind, Multicenter Study to Evaluate the Efficacy, Immunogenicity and Safety of Seqirus' Cell-Based Quadrivalent Subunit Influenza Virus Vaccine (QIVc) Compared to a Non-Influenza Vaccine When Administrated in Healthy Subjects Aged 6 Months Through 47 Months
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
84
A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults : A Phase 1, Comparator-Controlled, Dosage-Escalation Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
85
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy : Evaluation of Cell-mediated and Humoral Immunity Following COVID-19 in Pregnancy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
86
First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV, in Healthy Adults : VRC 325 (000410): A Phase I Open-Label Clinical Trial to Evaluate the Dose, Safety, Tolerability and Immunogenicity of Mosaic Quadrivalent Influenza Vaccine With and Without Adjuplex Compared With a Licensed Inactivated Seasonal QIV, In Healthy Adults
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
87
Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients : Multicenter, Randomized, Open, Phase III, Trial Assessing the Immunogenicity and Safety of Two Influenza Vaccine Strategies Among Severe Obese Adult Patients
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
88
A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19 : A Phase II, Randomized, Double-blind, Multi-centre Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Surface Antigen, Inactivated, Adjuvanted Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
89
Clinical Trial to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among HCP : Randomized Controlled Trial, Double Blind, Phase III, to Evaluate the Immunogenicity of an Adjuvanted Influenza Vaccine Among Health Care Personnel (EDUCATE)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
90
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults : A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in Healthy Adults 50 Years of Age or Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
4
5
6
7
8
9
10
11
12
13
14
Nächster »
[756]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
7.554
Aufsätze
7.554
E-Artikel
7.554
E-Ressourcen
Zeitschriftentitel
4.422
WHO International Clinical Trials Registry Plat...
3.132
ClinicalTrials.gov
Thema
7.554
610
6.494
Study Type: Interventional
3.516
Recruitment Status: Completed
1.997
Influenza, Human
1.667
Recruitment Status: Not yet recruiting
1.496
Phase: Phase 3
945
Study Type: Observational
886
Phase: Phase 2
806
Recruitment Status: Recruiting
775
Medical Condition: Influenza
729
Phase: Phase 1
668
Recruitment Status: Authorised-recruitment may ...
614
Phase: Phase 4
498
HIV Infections
492
Acquired Immunodeficiency Syndrome
190
Recruitment Status: Unknown status
175
Communicable Diseases
160
Infection
159
Immunologic Deficiency Syndromes
155
Recruitment Status: Active, not recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3.832
2020-
3.606
2010-2019
116
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7.484
Englisch
46
Unbestimmt
12
Spanisch
8
Dänisch
2
Niederländisch
2
Französisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...